Radiolabelled monoclonal antibodies in clinical and surgical oncology: A review

Panminerva Medica

Volumn 39, Issue 1, 1997, Pages 46-52

  Biassoni, L ^a   D'Andrea, V ^b,c   Biancari, F ^b   Santoni, F ^a   Dibra, A ^b   De Antoni, E ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Antibodies, monoclonal; Radioimmunoscintigraphy; Radioimmunotherapy; Scintigraphy; Surgery, radioimmunoguided

Indexed keywords

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

HUMAN; ISOTOPE LABELING; NEOPLASM; RADIOIMMUNOASSAY; REVIEW; SCINTISCANNING;

ANTIBODIES, MONOCLONAL; HUMANS; ISOTOPE LABELING; NEOPLASMS; RADIOIMMUNODETECTION;

EID: 0031089216     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Breitz HB, Durham JS, Fisher DR et al. Pharmakokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. J Nucl Med 1995; 36:754-61.
2. Burak WE Jr, Schneebaum S, Kim JA et al. Pilot study evaluating the intraoperative localization of radiolabelled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma. Surgery 1995;118:103-8.
3. Moffat FL, Vargas-Cuba RD. Serafini AN et al. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59. J Nucl Med 1995;36:738-45.
4. 131I labeled monoclonal antibody 3H11. Semin Surg Oncol 1994;10:88-94.
5. Neal CE, Meis LC. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer. Semin Nucl Med 1994;24:272-85.
6. Chan S, Sikora K. The potential of oncogene products as tumour markers. Cancer Surv 1987;6:185-207.
7. Sharkey RM, Goldenberg DM. Goldenberg H et al. Murine monoclonal antibodies against carcinoembryonic antigen: immunological pharmacokinetic and targeting properties in humans. Cancer Res 1990;50:2823-31.
8. 111In-labelled auto epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991;83:97-104.
9. Borreback CAK. Human mAbs produced by primary in vitro immunization, Immunol Today 1998,9:355-9.
10. Lo Buglio AF, Wheeler RH, Trang J et al. Mouse/human chimeric monoclonal antibody in men: Kinetics and immune response. Proc Natl Acad Sci USA 1989;86:4220-4.
11. 99mTc labelled monoclonal antibodies: a review. Nucl Med Commun 1993;14: 347-59.
12. Britton KE, Granowska M. Radioimmunoscintigraphty in tumour identification. Cancer Surv 1987,6:247-67.
13. Paganelli S, Perrez S, Siccardi AG et al. Intraperitoneal radio-localization of tumours pretargeted by biotinylated monoclonal antibodies. Int J Cancer 1990;31:1791-6.
14. Paganelli G, Magnani P, Zito F et al. Antibody guided tumour detection in CEA positive patients using the avidin-biotin system. Cancer Res 1991;51:5960-6.
15. Stella M, De Nardi P, Paganelli G et al. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis Colon Rectum 1994;37:335-43.
16. Burchiel SW, Rhodes BA. Radioimmunoimaging and radioimmunotherapy. New York: Elsevier, 1983.
17. Mather SJ, Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med 1990;31:692-7.